Ask AI
Bill116th CongressFiled Jan 24, 2020Health
H.R. 5668

MODERN Labeling Act of 2020

Bill journey · stage 2 of 5

Under committee review

Filed
Comm.
Floor
Both
Law

What it doesSummary passed house (Nov 17, 2020)

Making Objective Drug Evidence Revisions for New Labeling Act of 2020 or the MODERN Labeling Act of 2020

This bill authorizes the Food and Drug Administration (FDA) to require updates to outdated labels for certain generic drugs if the updates will provide a public health benefit. Generally, the FDA may use this authority to update the label of a generic version of a brand-name drug that has been withdrawn from the market for reasons other than safety or effectiveness.

What just happenedNov 18, 2020

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Who’s behind it

Rep. Matsui, Doris O. [D-CA-6](D-CA)Sponsor
2 cosponsors2 R
Read on Congress.gov
2cosponsors2committees18actions4related bills3subjects
  1. Nov 18, 2020IntroReferral

    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Health, Education, Labor, and Pensions Committee
  2. Nov 17, 2020FloorH38310

    Motion to reconsider laid on the table Agreed to without objection.

  3. Nov 17, 2020FloorH37300

    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5805-5806)

  4. Nov 17, 2020Floor8000

    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5805-5806)

  5. Nov 17, 2020FloorH8D000

    DEBATE - The House proceeded with forty minutes of debate on H.R. 5668.

  6. Nov 17, 2020FloorH30000

    Considered under suspension of the rules. (consideration: CR H5805-5807)

  7. Nov 17, 2020FloorH30300

    Mr. Pallone moved to suspend the rules and pass the bill, as amended.

  8. Nov 16, 2020CalendarsH12410

    Placed on the Union Calendar, Calendar No. 471.

  9. Nov 16, 2020CommitteeH12200

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-573.

    Energy and Commerce Committee
  10. Nov 16, 2020Committee5000

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-573.

    Energy and Commerce Committee
  11. Jul 15, 2020Committee

    Ordered to be Reported (Amended) by Voice Vote.

    Energy and Commerce Committee
  12. Jul 15, 2020Committee

    Committee Consideration and Mark-up Session Held.

    Energy and Commerce Committee
  13. Mar 11, 2020Committee

    Subcommittee Consideration and Mark-up Session Held.

    Health Subcommittee
  14. Mar 11, 2020Committee

    Ordered to be Reported (Amended) by Voice Vote.

    Energy and Commerce Committee
  15. Jan 25, 2020Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  16. Jan 24, 2020IntroReferralH11100

    Referred to the House Committee on Energy and Commerce.

    Energy and Commerce Committee
  17. Jan 24, 2020IntroReferralIntro-H

    Introduced in House

  18. Jan 24, 2020IntroReferral1000

    Introduced in House

Passed HouseNov 17, 202053

Making Objective Drug Evidence Revisions for New Labeling Act of 2020 or the MODERN Labeling Act of 2020

This bill authorizes the Food and Drug Administration (FDA) to require updates to outdated labels for certain generic drugs if the updates will provide a public health benefit. Generally, the FDA may use this authority to update the label of a generic version of a brand-name drug that has been withdrawn from the market for reasons other than safety or effectiveness.

Introduced in HouseJan 24, 2020

Making Objective Drug Evidence Revisions for New Labeling Act of 2020 or the MODERN Labeling Act of 2020

This bill authorizes the Food and Drug Administration (FDA) to require updates to outdated labels for certain generic drugs if the updates will provide a public health benefit. Generally, the FDA may use this authority to update the label of a generic version of a brand-name drug that has been withdrawn from the market for reasons other than safety or effectiveness.

MODERN Labeling Act of 2020 — Informed